Women have the power: When motor efficiency makes the difference in older individuals of the sardinian blue zone.

This study was mainly aimed at exploring the effect of gender on the patterns of Physical Activty (PA) in older people living in an area of exceptional longevity, the so-called Sardinian Blue Zone. Furthermore, the study intended to investigate the nature of the relationships among PA metrics, cognitive measures, and age. One hundred and nine community-dwelling participants (M = 81.

Older workers spend less time in extreme trunk and upper-arm postures during order-picking tasks: Results from field testing.

Order picking tasks require repetitive trunk and upper arms movements that may increase the risk of developing musculoskeletal disorders, particularly among older workers due to the decline of their physical capabilities with aging. We proposed an approach based on a limited number of wearable inertial sensors to assessed exposures to non-neutral trunk and upper arms postures among both older and young workers during their regular work-shifts. The obtained data were processed accordingly to international standards (ISO 11226 and EN 1005-4) to detect the existence of possible differences associated with age-specific working strategies.

Manifestations of walking fatigability in people with multiple sclerosis based on gait quality and distance walked during the six minutes walking test.

Background: Distance walking fatigability (DWF) in people with multiple sclerosis (pwMS) is defined as a decrease in the distance walking over time. However, declines in gait quality (i.e.

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.

Background: The HVTN 705 Imbokodo trial of 2636 people without HIV and assigned female sex at birth, conducted in southern Africa, evaluated a heterologous HIV-1 vaccine regimen: mosaic adenovirus 26-based vaccine (Ad26.Mos4.HIV) at Months 0, 3, 6, 12 and alum-adjuvanted clade C gp140 at Months 6, 12.